In the latest issue! mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant dlvr.it/SJNGqR

In the latest issue! Omicron’s message on vaccines: Boosting begets breadth dlvr.it/SJPxQp

Paper comparing vaccine effectiveness based on Puerto Rico data finally published: sciencedirect.com/science/articl… Unpopular conclusion, J&J not as effective, and it being an observational study made publishing challenging. Nice to see confirmation from independent lab-based study:

Attention Mass undergrads and community college students who went to HS in Boston, Cambridge, Revere, Brockton or other gateway city: check out the RISE summer internships at the Ragon Institute. DM me with questions. ragoninstitute.org/get-involved/i…

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals ✏️ Wilfredo F. Garcia-Beltran, MD, PhD 7, A John Iafrate 4 🗓️ 2022 Feb 3 🌐 pubmed.ncbi.nlm.nih.gov/35202566/ #MGHPathPublication

ICYMI: watch the recording of the Cambridge Public Library event "Variants, Breakthroughs, and Boosters: Understanding Omicron and the Future of the COVID-19 Pandemic." Wilfredo F. Garcia-Beltran, MD, PhD and Gaurav Gaiha were guest speakers with Cambridge Public Health Dept director Derrick Neal. youtube.com/watch?v=X_7sjS…

#Host #immune #epigenetic reader #SP140 creates an antibacterial setpoint that sensitizes #mice & #humans to #gut #inflammation. Welcome Isabella Fraschilla to twitter for her study led by Kate Jeffrey. Harvard Immunology Harvard Medical School @MGH_RI Broad Institute biorxiv.org/content/10.110…

Excited to share our preprint on how an #epigenetic reader controls the #intestinal #microbiota. Thanks to @HajeraAmatullah & Kate Jeffrey. #SP140 #antibacterial #macrophages MassGeneral News Harvard Medical School biorxiv.org/content/10.110…

Vectored ImmunoProphylaxis (VIP) produces broadly neutralizing antibody (VRC07) in humans! I'm incredibly proud to have been able to participate in the development of VIP from the very beginning and am excited to see where this goes next! nature.com/articles/s4159…

AddThis | Home authors.elsevier.com/a/1exmgL7PXio3… Checkout Aaron Rongqing Pan's new paper just out today online in Cell . NK cells don't kill by magic, they exploit target cell programmed cell death pathways, and these can be augmented by drugs to make NKs kill better. 1/2

We are hiring at the ⁦Puerto Rico Science, Technology & Research Trust⁩. We are looking for a dynamic and highly motivated person to lead our Sponsored Research Programs Office. Great salary. Awesome place to work! glassdoor.com/partner/jobLis…

Our preprint showing that SARS-CoV-2 ORF7a inhibits antigen presentation by disrupting the MHC-I peptide loading complex is out. Led by Fengwen Zhang with help from Trinity Zang and great collaboration with Brad Jones Lab Wilfredo F. Garcia-Beltran, MD, PhD, and Julie Boucau biorxiv.org/content/10.110…

During #NationalHispanicHeritageMonth, we spoke with Wilfredo F. Garcia-Beltran, MD, PhD. "It’s really important to develop a support system ... You’ll feel so justified and validated and know that yes, you can." ragoninstitute.org/latest-news/fi…

Let the holidays begin! Spectacular performance by the Ragon Institute choir at our Winter Holiday Party. Kudos to Choirmaster and NK cell maven Wilfredo Garcia-Beltran and the rest of the harmonious members!

Our new paper delineates #ROS #control of #GSDMD #pore forming activity. C192 is necessary & sufficient for ROS #enhancement of pores and #pyroptosis. #Ragulator controls one arm of many potential ROS inputs. Cell Reports Ragon Institute Harvard Medical School cell.com/cell-reports/f…

Check out the latest work from Blake Hauser in Cell Reports Medicine! Yet another wonderful collaboration with Lingwood Lab Balazs Lab Wilfredo F. Garcia-Beltran, MD, PhD. Ragon Institute Harvard Micro The Harvard/MIT MD-PhD Program The PhD Program in Virology at HMS cell.com/cell-reports-m…

Why I love my job: PRISM Science Club 2023 of Ragon Institute and MIT IMES is off to a great start! After a a fantastic talk by Ragon Director Bruce D. Walker we learned about transfusion medicine, blood typing, and killer T-cells from physician-scientist Wilfredo F. Garcia-Beltran, MD, PhD

Preprint: SARS-CoV-2 evades NKG2D recognition by ORF6-mediated downregulation of MIC-A/B via shedding, which could be suppressed to enhance NK cell killing of infected cells Wilfredo F. Garcia-Beltran, MD, PhD dx.doi.org/10.2139/ssrn.4…

The study led by faculty member Wilfredo F. Garcia-Beltran, MD, PhD and BSL3 Core co-director Julie Boucau has provided new insights that could lead to novel treatments. ragoninstitute.org/latest-news/ra… #COVID19 #ScienceNews #Immunology #Cell #Research

The #Evavold lab Ragon Institute is hiring a new #technician. Please retweet & share the link below. Ideal for recent grads looking for a couple years of research experience prior to MD or PhD. partners.taleo.net/careersection/…